Asmanex approved for adult asthma in Japan
This article was originally published in Scrip
Executive Summary
Schering-Plough's once-daily inhaled corticosteroid Asmanex (mometasone furoate) has been approved in Japan. The dry powder product is delivered through the breath-activated Twisthaler system and indicated for the treatment of adult bronchial asthma.